Orion Group Financial Statement documents 2016 and Corporate Governance Statement published

(Thomson Reuters ONE) -


ORION CORPORATION         STOCK EXCHANGE RELEASE 27 FEBRUARY 2017 at 13.00
EET

Orion Group Financial Statement documents 2016 and Corporate Governance
Statement published

Orion Group's Financial Statement documents for 2016 have been published. The
documents are available in Finnish and English on the Company's website at
http://www.orion.fi/en.

The official financial statement documents, which include the financial
statements, the report of the Board of Directors and the auditor's report are
available in Finnish at http://www.orion.fi/yhtiokokous2017.

Orion's Corporate Governance Statement for year 2016, adopted by the Board of
Directors, is published as a separate report in Finnish and English on the
Company's website at http://www.orion.fi/en.


Orion Corporation



Olli Huotari   Terhi Ormio
SVP, Corporate Functions VP, Communications





Contact person:
Tuukka Hirvonen, Communications Manager, IR & Financial Communications
tel. +358 10 426 2721


Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage: www.orion.fi


Orion is a globally operating Finnish pharmaceutical company - a builder of
well-being. Orion develops, manufactures and markets human and veterinary
pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The
company is continuously developing new drugs and treatment methods. The core
therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS)
disorders, oncology and respiratory for which Orion developes inhaled Easyhaler®
pulmonary drugs. Orion's net sales in 2016 amounted to EUR 1,074 million and the
company had about 3,500 employees. Orion's A and B shares are listed on Nasdaq
Helsinki. Founded in 1917, Orion celebrates its centennial anniversary in 2017.

Orion Financial Statement Documents 2016:
http://hugin.info/3079/R/2081915/784397.pdf

Orion Corporate Governance Statement 2016:
http://hugin.info/3079/R/2081915/784398.pdf



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Orion Oyj via GlobeNewswire

Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 27.02.2017 - 12:00 Uhr
Sprache: Deutsch
News-ID 526705
Anzahl Zeichen: 2727

contact information:
Town:

Espoo

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 200 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Orion Group Financial Statement documents 2016 and Corporate Governance Statement published"
steht unter der journalistisch-redaktionellen Verantwortung von

Orion Oyj (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Orion Receives Positive Phase II Study Results of a New Levodopa Product for Par ...

ESPOO, FINLAND -- (Marketwire) -- 10/24/12 -- ODM-101, a new levodopa product currently developed by Orion for the treatment of Parkinson's disease, has successfully completed Phase II Proof of Concept trial. The key results indicate that ODM-1 ...

200,000 Orion A-shares converted into B-shares ...

Orion clarifies information emanating from Capital Markets Day ...

ORION CORPORATION STOCK EXCHANGE RELEASE 4 DECEMBER 2009 at 17.00 p.m. Orion Corporation is clarifying information emanating from the Capital Markets Day on 1 December 2009 concerning the number of companies that have submitted Abbre ...

Alle Meldungen von Orion Oyj